Sort by
Refine Your Search
-
Posting Details Position Details Title Postdoctoral Fellow: Evolution of Social Behavior Appointment Status Non-Tenure Track Department IU Bloomington Biology Location Bloomington Position Summary
-
develop safer and more effective gene therapies for muscular dystrophy and cardiovascular disease. Dr. Han’s laboratory environment uses pharmacologic, genetic and biochemical approaches, including
-
waste. The projects are highly collaborative and multidisciplinary with excellent opportunities for advanced training and scientific development. Interested candidates will possess significant experience
-
focuses on the synthesis and spectroscopy of colloidal inorganic nanomaterials, particularly binary and ternary transition metal oxides, chalcogenides, and pnictides. Research topics range from developing
-
— from ecosystems to microbiology and developmental biology, from evolution to cell biology, from molecular biology to systems biology, bioinformatics, and genomics. It is always an exciting time for
-
Laboratories to pursue cutting-edge scientific research. The incumbent will have the opportunity to participate in professional development activities according to their professional goals. These include grant
-
page statement outlining the applicant’s research interests and professional development goals 4. one writing sample (15-25 pages); 5. the names of 2–3 referees. For Best Consideration Date 05/12/2026
-
of Medicine, and study normal and pathological development of the human inner ear using stem cell-derived organoids as a model system (Koehler et al., Nature Biotechnology 2017; Nie et al., Nature
-
Pharmacology conducts groundbreaking translational research in the area of cardio-immunology, drug discovery and development, drug interactions, and genomic variants that impact therapeutic effectiveness
-
discovery to identify children at risk for developing kidney disease and to guide personalized treatment strategies. By leveraging advanced technologies in genomics, proteomics, and metabolomics, our goal is